What Is Cardiotocography?

Heart failure means that the heart muscle is severely damaged and the heart cannot normally pump enough blood to supply the needs of the activities and metabolism of various organs in the body. As a result, the heart gradually becomes enlarged and loses heart function. This is called heart failure.

heart failure

Heart failure means

Heart failure is divided into congestive heart failure or heart failure, which is caused by abnormal performance or impairment of structure or function, resulting in

according to

Not everyone accepts yet

There are many ways to classify heart failure, including:

influenced

The causes and causes of heart failure are:

treatment

The treatment of heart failure is mainly the treatment of its symptoms to prevent heart failure from becoming more serious. If there is a reversible cause of heart failure, such as infection,

There is a gap between practice and facts when treating heart failure, and fact observations find that

The most serious patients require inpatient care.

Home care measures

1 Exercise Avoid strenuous exercise. Resting can reduce the load on the heart and relieve symptoms, including physical and mental rest. Choose slow but not too hard exercise, such as walking, jogging, qigong, Tai Chi, etc. Cardiac function level , activity is not restricted; cardiac function level , activity limitation, appropriate rest; cardiac function level , bed rest; cardiac function level , absolute bed rest.
2 Long-term bedridden patients should often do deep breathing exercises, and help and encourage physical activities, especially the lower limbs, to prevent muscle atrophy. Pay attention to the prevention and treatment of venous embolism, bedsores, and constipation. You can massage the whole body with positive safflower oil and turn over frequently. Generally, you should turn over every 2h. The sheets should be clean and free of wrinkles. Eat more fruits and vegetables, keep your stools open, and quit smoking and alcohol.
3 Keep the air fresh and the environment quiet and open the windows regularly every day for ventilation, but avoid air convection to prevent patients from getting cold. Temperature and humidity are suitable. Generally, keep warm in winter. Room temperature is 22 24 and humidity is 50% 60%. should.
4 Maintain a good mood and adequate sleep to make good psychological adjustments, improve self-control ability, live carefully, live regularly, and eat a light diet. High vitamins, low calories, low salt, and frequent meals. Women of childbearing age pay attention to contraception.
5 Self-monitoring society observes his heart rate, blood pressure, urine volume, weight and adverse reactions to the drug 'it is not appropriate to stop the drug at the same time' while paying attention to preventing and controlling infection.
6 Period of re-examination and indications. Periodic re-examination, timely visits to the hospital in the following circumstances: (1) Sudden oliguria and bloating during taking diuretics; (2) fever, cough, frequent urination, urgency and other infection symptoms; 3) Swelling, palpitation, shortness of breath, nausea, bloating, and abdominal pain; (4) When taking digitalis preparations, symptoms such as fatigue, nausea, vomiting, diarrhea, and yellow vision appear.

2000). "Predictors of readmission among elderly survivors of admission with heart failure". Am. Heart J .. 139 (1 Pt 1): 72-7.

^ McKee PA, Castelli WP, McNamara PM, Kannel WB (1971). "The natural history of congestive heart failure: the Framingham study". N. Engl. J. Med .. 285 (26): 1441-6.

^ Carlson KJ, Lee DC, Goroll AH, Leahy M, Johnson RA (1985). "An analysis of physicians' reasons for prescribing long-term digitalistherapy in outpatients". Journal of chronic diseases. 38 (9): 733-9.

^ Harlan WR, oberman A, Grimm R, Rosati RA (1977). "Chronic congestive heart failure in coronary artery disease: clinical criteria". Ann. Intern. Med .. 86 (2): 133-8.

^ Killip T, Kimball JT (1967). "Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients". Am. J. Cardiol .. 20 (4): 457-64.

^ Criteria Committee, New York Heart Association. Diseases of the heart and blood vessels. Nomenclature and criteria for diagnosis, 6th ed. Boston: Little, Brown and co, 1964; 114.

^ Raphael C, Briscoe C, Davies J, et al (2007). "Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure". Heart. 93 (4): 476-82. DOI: 10.1136 / hrt. 2006.089656.

^

^ Chaudhry SI et al (2007). "Patterns of Weight Change Preceding Hospitalization for Heart Failure". Circulation. DOI: 10.1161 / CIRCULATIONAHA.107.690768.

^ Jackson S, Bereznicki L, Peterson G. Under-use of ACE-inhibitor and -blocker therapies in congestive cardiac failure. Australian Pharmacist 2005; 24 (12): 936.

^ Packer M (1989). "Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure". Am. J. Cardiol .. 63 (2): 41A-45A.

^ Packer M, Carver JR, Rodeheffer RJ, et al (1991). "Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group". N. Engl. J. Med .. 325 (21): 1468-75.

^ Krum H, National Heart Foundation of Australia and Cardiac Society of Australia & amp; New Zealand Chronic Heart Failure Clinical Practice Guidelines Writing Panel. (2001). "Guidelines for management of patients with chronic heart failure in Australia.". Med J Aust. 174 (9): 459-66. PMID 11386592.

^

^ Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. (2003). "Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic functionintolerantto angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.". Lancet. 362 (9386): 772-6. PMID 13678870.

^ Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S; CHARM Investigators and Committees. (2003). "Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.". Lancet. 362 (9386): 759-66. PMID 13678868.

^ Haji SA, Movahed A (2000). "Update on digoxin therapy in congestive heart failure". American family physician. 62 (2): 409-16.

^ Exner DV, Dries DL, Domanski MJ, Cohn JN (2001). "Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.". N Engl J Med .. 344 (18): 1351-7. PMID 11333991.

^ Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators. (2004). "Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.". N Engl J Med. 351 (20): 2049-57. PMID 15533851.

^ Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. (2005). "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.". N Engl J Med. 352 (3): 225-37. PMID 15659722.

Taken from "; variant = zh-cn"